Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Diabetologist
M.B.B.S., DipDiab
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Diabetologist
MD
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), MACG (USA), UEG GI ASSOCIATE (VIENNA), MMED Gastroenterology Fellow (UK)
Internal Medicine Specialist
M.B.B.S., MRCP UK
Diabetologist
MBBS, M.Sc. (Diabetes & Endocrinology)
Cardiologist
MBBS, FCPS (Medicine), FCPS (Cardiology)
Gastroenterologist
M.B.B.S, F.C.P.S, MRCP
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures